Jeremy Davis - Feb 21, 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP Chief Commercial Officer
Signature
/s/ Jeremy Davis
Stock symbol
LAB
Transactions as of
Feb 21, 2023
Transactions value $
-$12,537
Form type
4
Date filed
2/23/2023, 08:45 PM
Previous filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 +20.8K $0.00 20.8K Feb 21, 2023 Direct
transaction LAB Common Stock Tax liability -$12.5K -6.18K -29.65% $2.03 14.7K Feb 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Options Exercise $0 -20.8K -8.33% $0.00 229K Feb 21, 2023 Common Stock 20.8K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.